
Michael Ison
@michaelisonmd
#TxID physician at @NM_IDSteward focusing on donor-derived and viral infections
ID: 3344312890
24-06-2015 16:25:46
3,3K Tweet
1,1K Followers
0 Following




A team of Northwestern researchers—including ISGMH Director Brian Mustanski, PhD and affiliate faculty member Richard D’Aquila—have developed a finger stick #antibody test to determine whether an individual has had prior exposure to the virus that causes #COVID19. buff.ly/3cfuHeq

Proud of my friend Michael Ison for speaking out regarding the lack of transparency on Remdesivir Allocation: the public should be outraged wsj.com/articles/healt…



Maybe it is time to move on. Northwestern ID & Antimicrobial Stewardship NU Internal Medicine


The largest study of mortality risk w/ #COVID19 from >17 million UK patients, > 5,600 in-hospital deaths, a medRxiv today, by Ben Goldacre and colleagues London School of Hygiene & Tropical Medicine medrxiv.org/content/10.110… Note: age, diabetes, Asian & African ancestry, male, obesity, cancer, asthma (not HTN)


Who’s gets remdesivir? After much confusion, Massachusetts government…so proud of our hospitals and MA DPH for ensuring equitable access #WeAreID Tufts Medical Center IDSA @TuftsCIMAR Rochelle Walensky, MD, MPH bostonglobe.com/2020/05/07/nat…





We just went past 10,000 decontaminated and safely reused N95 masks through the Duke Health - this has been a huge effort from environmental safety experts to keep us all safe!! Duke Human Vaccine Institute #PPEshortage


Remdesivir for covid-19: Doctors are flying blind in deciding which patients should get the drug - The Washington Post IDSA Rochelle Walensky, MD, MPH Michael Ison washingtonpost.com/opinions/2020/…
